+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Fungal Keratitis Treatment Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2032 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)

  • PDF Icon

    Report

  • 227 Pages
  • March 2025
  • Region: Global
  • Fairfield Market Research
  • ID: 6055887
Description Jump to:
The global fungal keratitis treatment market is witnessing substantial growth, driven by advancements in diagnostics and antifungal drug formulations. The market is projected to grow at a CAGR of 6.05%, reaching a valuation of USD 717.62 million in 2025 and USD 1.08 billion by 2032. Fungal keratitis, a severe corneal infection caused by fungi such as Fusarium and Aspergillus, demands effective therapeutic interventions to prevent vision impairment and blindness.

Market Insights

Fungal keratitis treatment encompasses systemic and topical antifungal medications, with surgical interventions required in severe cases. Increasing awareness of eye health, along with advancements in antifungal drug research and diagnostic technologies, is fueling market expansion. A rising global incidence of fungal eye infections is prompting key industry players to focus on research and development, leading to innovative treatment solutions.

Market Growth Drivers

  • Advancements in Diagnostic and Treatment Technologies: Innovations such as next-generation sequencing and polymerase chain reaction (PCR) techniques are enhancing the speed and accuracy of fungal keratitis diagnosis, facilitating timely treatment.
  • Rising Prevalence of Fungal Eye Infections: Factors such as increased contact lens usage, changing climatic patterns, and higher outdoor activity levels are contributing to a surge in fungal eye infections, thereby boosting market demand.
  • Pharmaceutical Innovations: Ongoing research into novel antifungal formulations and targeted drug delivery methods is improving treatment outcomes and expanding market opportunities.

Business Opportunities

  • Expansion in Emerging Markets: Developing regions are witnessing increased investments in healthcare infrastructure, leading to enhanced accessibility to advanced fungal keratitis treatments.
  • Collaborations and Partnerships: Pharmaceutical companies, academic institutions, and healthcare organizations are partnering to introduce next-generation antifungal therapies.
  • Innovative Treatment Approaches: The development of improved antifungal drugs, specialized ophthalmic formulations, and more effective drug delivery systems presents lucrative market opportunities.

Market Restraints

  • High Treatment Costs: The accessibility of advanced diagnostic tools and antifungal drugs remains limited in some regions due to financial constraints.
  • Regulatory Challenges: Strict regulatory approval processes can prolong drug development timelines and increase research costs, impacting the availability of innovative treatments.

Regional Analysis

  • North America: Dominates the market due to strong healthcare infrastructure, high awareness levels, and continuous advancements in treatment methodologies.
  • South Asia & Oceania: Emerging as the fastest-growing region, driven by an increasing incidence of fungal eye infections, improving healthcare facilities, and greater accessibility to treatment options.
  • Europe, Latin America, and Middle East & Africa: Witnessing steady growth, supported by rising investments in ophthalmic research and increasing awareness among healthcare professionals.

Competitive Analysis

Leading pharmaceutical companies are actively engaging in strategic initiatives, including product launches, partnerships, and acquisitions, to strengthen their market position. Research and development efforts are focused on introducing more effective antifungal treatments and enhancing drug delivery mechanisms. Companies are expanding their geographical reach to address unmet medical needs in developing regions.

Key Players in the Market

  • Novartis AG
  • Eyevance Pharmaceuticals, LLC (Santen Holdings United States Inc.)
  • AbbVie Inc.
  • Pfizer Inc.
  • Merck and Co. (Merck KGaA)
  • Bausch Health Companies Inc.
  • Cipla Inc.
  • Wellona Pharma
  • LEXICARE PHARMA PVT. LTD
  • Salvus Pharma

Recent Developments

  • Product Launch by Harrow: In October 2023, Harrow successfully acquired New Drug Applications (NDAs) for FLAREX®, NATACYN®, and TOBRADEX® ST, strengthening its pharmaceutical portfolio in the eye care segment.
  • Breakthrough Research in India: An all-female research team at the Indian Institute of Technology (IIT) Delhi developed an innovative antifungal strategy for treating ocular infections, potentially revolutionizing fungal keratitis treatment.

Fungal Keratitis Treatment Market Research Segmentation

By Type:

  • Aspergillus keratitis
  • Fusarium keratitis
  • Candida keratitis
  • Other fungal keratitis (e.g., Cryptococcus neoformans, Mucorales)

By Drug Formulation:

  • Tablets
  • Eye Drops
  • Ophthalmic Ointments
  • Subconjunctival Injections

By Route of Administration:

  • Topical eye drops or ointments
  • Oral antifungal medications
  • Intravenous (IV) antifungal medications (for severe or invasive fungal keratitis)

By End User:

  • Hospitals and clinics
  • Ophthalmic centers and eye hospitals
  • Ambulatory surgical centers (ASCs)
  • Homecare settings

By Region:

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa

This product will be delivered within 1-3 business days.

Table of Contents

1. Executive Summary
1.1. Global Fungal Keratitis Treatment Market Snapshot
1.2. Future Projections
1.3. Key Market Trends
1.4. Regional Snapshot, by Value, 2025
1.5. Analyst Recommendations
2. Market Overview
2.1. Market Definitions and Segmentations
2.2. Market Dynamics
2.2.1. Drivers
2.2.2. Restraints
2.2.3. Market Opportunities
2.3. Value Chain Analysis
2.4. Porter’s Five Forces Analysis
2.5. COVID-19 Impact Analysis
2.5.1. Supply
2.5.2. Demand
2.6. Impact of Ukraine-Russia Conflict
2.7. Economic Overview
2.7.1. World Economic Projections
2.8. PESTLE Analysis
3. Global Fungal Keratitis Treatment Market Outlook, 2019 - 2032
3.1. Global Fungal Keratitis Treatment Market Outlook, by Type, Value (US$ Mn), 2019 - 2032
3.1.1. Key Highlights
3.1.1.1. Aspergillus keratitis
3.1.1.2. Fusarium keratitis
3.1.1.3. Candida keratitis
3.1.1.4. Other fungal keratitis
3.2. Global Fungal Keratitis Treatment Market Outlook, by Drug Formulation, Value (US$ Mn), 2019 - 2032
3.2.1. Key Highlights
3.2.1.1. Tablets
3.2.1.2. Eye Drops
3.2.1.3. Ophthalmic Ointments
3.2.1.4. Subconjunctival Injections
3.3. Global Fungal Keratitis Treatment Market Outlook, by Administration, Value (US$ Mn), 2019 - 2032
3.3.1. Key Highlights
3.3.1.1. Topical eye drops or ointments
3.3.1.2. Oral antifungal medications
3.3.1.3. Intravenous (IV) antifungal medications
3.4. Global Fungal Keratitis Treatment Market Outlook, by End User, Value (US$ Mn), 2019 - 2032
3.4.1. Key Highlights
3.4.1.1. Hospitals and clinics
3.4.1.2. Ophthalmic centers and eye hospitals
3.4.1.3. Ambulatory surgical centers (ASCs)
3.4.1.4. Homecare settings
3.5. Global Fungal Keratitis Treatment Market Outlook, by Region, Value (US$ Mn), 2019 - 2032
3.5.1. Key Highlights
3.5.1.1. North America
3.5.1.2. Europe
3.5.1.3. Asia Pacific
3.5.1.4. Latin America
3.5.1.5. Middle East & Africa
4. North America Fungal Keratitis Treatment Market Outlook, 2019 - 2032
4.1. North America Fungal Keratitis Treatment Market Outlook, by Type, Value (US$ Mn), 2019 - 2032
4.1.1. Key Highlights
4.1.1.1. Aspergillus keratitis
4.1.1.2. Fusarium keratitis
4.1.1.3. Candida keratitis
4.1.1.4. Other fungal keratitis
4.2. North America Fungal Keratitis Treatment Market Outlook, by Drug Formulation, Value (US$ Mn), 2019 - 2032
4.2.1. Key Highlights
4.2.1.1. Tablets
4.2.1.2. Eye Drops
4.2.1.3. Ophthalmic Ointments
4.2.1.4. Subconjunctival Injections
4.3. North America Fungal Keratitis Treatment Market Outlook, by Administration, Value (US$ Mn), 2019 - 2032
4.3.1. Key Highlights
4.3.1.1. Topical eye drops or ointments
4.3.1.2. Oral antifungal medications
4.3.1.3. Intravenous (IV) antifungal medications
4.4. North America Fungal Keratitis Treatment Market Outlook, by End User, Value (US$ Mn), 2019 - 2032
4.4.1. Key Highlights
4.4.1.1. Hospitals and clinics
4.4.1.2. Ophthalmic centers and eye hospitals
4.4.1.3. Ambulatory surgical centers (ASCs)
4.4.1.4. Homecare settings
4.4.2. BPS Analysis/Market Attractiveness Analysis
4.5. North America Fungal Keratitis Treatment Market Outlook, by Country, Value (US$ Mn), 2019 - 2032
4.5.1. Key Highlights
4.5.1.1. U.S. Fungal Keratitis Treatment Market by Type, Value (US$ Mn), 2019 - 2032
4.5.1.2. U.S. Fungal Keratitis Treatment Market by Drug Formulation, Value (US$ Mn), 2019 - 2032
4.5.1.3. U.S. Fungal Keratitis Treatment Market by Administration, Value (US$ Mn), 2019 - 2032
4.5.1.4. U.S. Fungal Keratitis Treatment Market by End User, Value (US$ Mn), 2019 - 2032
4.5.1.5. Canada Fungal Keratitis Treatment Market by Type, Value (US$ Mn), 2019 - 2032
4.5.1.6. Canada Fungal Keratitis Treatment Market by Drug Formulation, Value (US$ Mn), 2019 - 2032
4.5.1.7. Canada Fungal Keratitis Treatment Market by Administration, Value (US$ Mn), 2019 - 2032
4.5.1.8. Canada Fungal Keratitis Treatment Market by End User, Value (US$ Mn), 2019 - 2032
4.5.2. BPS Analysis/Market Attractiveness Analysis
5. Europe Fungal Keratitis Treatment Market Outlook, 2019 - 2032
5.1. Europe Fungal Keratitis Treatment Market Outlook, by Type, Value (US$ Mn), 2019 - 2032
5.1.1. Key Highlights
5.1.1.1. Aspergillus keratitis
5.1.1.2. Fusarium keratitis
5.1.1.3. Candida keratitis
5.1.1.4. Other fungal keratitis
5.2. Europe Fungal Keratitis Treatment Market Outlook, by Drug Formulation, Value (US$ Mn), 2019 - 2032
5.2.1. Key Highlights
5.2.1.1. Tablets
5.2.1.2. Eye Drops
5.2.1.3. Ophthalmic Ointments
5.2.1.4. Subconjunctival Injections
5.3. Europe Fungal Keratitis Treatment Market Outlook, by Administration, Value (US$ Mn), 2019 - 2032
5.3.1. Key Highlights
5.3.1.1. Topical eye drops or ointments
5.3.1.2. Oral antifungal medications
5.3.1.3. Intravenous (IV) antifungal medications
5.4. Europe Fungal Keratitis Treatment Market Outlook, by End User, Value (US$ Mn), 2019 - 2032
5.4.1. Key Highlights
5.4.1.1. Hospitals and clinics
5.4.1.2. Ophthalmic centers and eye hospitals
5.4.1.3. Ambulatory surgical centers (ASCs)
5.4.1.4. Homecare settings
5.4.2. BPS Analysis/Market Attractiveness Analysis
5.5. Europe Fungal Keratitis Treatment Market Outlook, by Country, Value (US$ Mn), 2019 - 2032
5.5.1. Key Highlights
5.5.1.1. Germany Fungal Keratitis Treatment Market by Type, Value (US$ Mn), 2019 - 2032
5.5.1.2. Germany Fungal Keratitis Treatment Market by Drug Formulation, Value (US$ Mn), 2019 - 2032
5.5.1.3. Germany Fungal Keratitis Treatment Market by Administration, Value (US$ Mn), 2019 - 2032
5.5.1.4. Germany Fungal Keratitis Treatment Market by End User, Value (US$ Mn), 2019 - 2032
5.5.1.5. U.K. Fungal Keratitis Treatment Market by Type, Value (US$ Mn), 2019 - 2032
5.5.1.6. U.K. Fungal Keratitis Treatment Market by Drug Formulation, Value (US$ Mn), 2019 - 2032
5.5.1.7. U.K. Fungal Keratitis Treatment Market by Administration, Value (US$ Mn), 2019 - 2032
5.5.1.8. U.K. Fungal Keratitis Treatment Market by End User, Value (US$ Mn), 2019 - 2032
5.5.1.9. France Fungal Keratitis Treatment Market by Type, Value (US$ Mn), 2019 - 2032
5.5.1.10. France Fungal Keratitis Treatment Market by Drug Formulation, Value (US$ Mn), 2019 - 2032
5.5.1.11. France Fungal Keratitis Treatment Market by Administration, Value (US$ Mn), 2019 - 2032
5.5.1.12. France Fungal Keratitis Treatment Market by End User, Value (US$ Mn), 2019 - 2032
5.5.1.13. Italy Fungal Keratitis Treatment Market by Type, Value (US$ Mn), 2019 - 2032
5.5.1.14. Italy Fungal Keratitis Treatment Market by Drug Formulation, Value (US$ Mn), 2019 - 2032
5.5.1.15. Italy Fungal Keratitis Treatment Market by Administration, Value (US$ Mn), 2019 - 2032
5.5.1.16. Italy Fungal Keratitis Treatment Market by End User, Value (US$ Mn), 2019 - 2032
5.5.1.17. Turkey Fungal Keratitis Treatment Market by Type, Value (US$ Mn), 2019 - 2032
5.5.1.18. Turkey Fungal Keratitis Treatment Market by Drug Formulation, Value (US$ Mn), 2019 - 2032
5.5.1.19. Turkey Fungal Keratitis Treatment Market by Administration, Value (US$ Mn), 2019 - 2032
5.5.1.20. Turkey Fungal Keratitis Treatment Market by End User, Value (US$ Mn), 2019 - 2032
5.5.1.21. Russia Fungal Keratitis Treatment Market by Type, Value (US$ Mn), 2019 - 2032
5.5.1.22. Russia Fungal Keratitis Treatment Market by Drug Formulation, Value (US$ Mn), 2019 - 2032
5.5.1.23. Russia Fungal Keratitis Treatment Market by Administration, Value (US$ Mn), 2019 - 2032
5.5.1.24. Russia Fungal Keratitis Treatment Market by End User, Value (US$ Mn), 2019 - 2032
5.5.1.25. Rest of Europe Fungal Keratitis Treatment Market by Type, Value (US$ Mn), 2019 - 2032
5.5.1.26. Rest of Europe Fungal Keratitis Treatment Market by Drug Formulation, Value (US$ Mn), 2019 - 2032
5.5.1.27. Rest of Europe Fungal Keratitis Treatment Market by Administration, Value (US$ Mn), 2019 - 2032
5.5.1.28. Rest of Europe Fungal Keratitis Treatment Market by End User, Value (US$ Mn), 2019 - 2032
5.5.2. BPS Analysis/Market Attractiveness Analysis
6. Asia Pacific Fungal Keratitis Treatment Market Outlook, 2019 - 2032
6.1. Asia Pacific Fungal Keratitis Treatment Market Outlook, by Type, Value (US$ Mn), 2019 - 2032
6.1.1. Key Highlights
6.1.1.1. Aspergillus keratitis
6.1.1.2. Fusarium keratitis
6.1.1.3. Candida keratitis
6.1.1.4. Other fungal keratitis
6.2. Asia Pacific Fungal Keratitis Treatment Market Outlook, by Drug Formulation, Value (US$ Mn), 2019 - 2032
6.2.1. Key Highlights
6.2.1.1. Tablets
6.2.1.2. Eye Drops
6.2.1.3. Ophthalmic Ointments
6.2.1.4. Subconjunctival Injections
6.3. Asia Pacific Fungal Keratitis Treatment Market Outlook, by Administration, Value (US$ Mn), 2019 - 2032
6.3.1. Key Highlights
6.3.1.1. Topical eye drops or ointments
6.3.1.2. Oral antifungal medications
6.3.1.3. Intravenous (IV) antifungal medications
6.4. Asia Pacific Fungal Keratitis Treatment Market Outlook, by End User, Value (US$ Mn), 2019 - 2032
6.4.1. Key Highlights
6.4.1.1. Hospitals and clinics
6.4.1.2. Ophthalmic centers and eye hospitals
6.4.1.3. Ambulatory surgical centers (ASCs)
6.4.1.4. Homecare settings
6.4.2. BPS Analysis/Market Attractiveness Analysis
6.5. Asia Pacific Fungal Keratitis Treatment Market Outlook, by Country, Value (US$ Mn), 2019 - 2032
6.5.1. Key Highlights
6.5.1.1. China Fungal Keratitis Treatment Market by Type, Value (US$ Mn), 2019 - 2032
6.5.1.2. China Fungal Keratitis Treatment Market by Drug Formulation, Value (US$ Mn), 2019 - 2032
6.5.1.3. China Fungal Keratitis Treatment Market by Administration, Value (US$ Mn), 2019 - 2032
6.5.1.4. China Fungal Keratitis Treatment Market by End User, Value (US$ Mn), 2019 - 2032
6.5.1.5. Japan Fungal Keratitis Treatment Market by Type, Value (US$ Mn), 2019 - 2032
6.5.1.6. Japan Fungal Keratitis Treatment Market by Drug Formulation, Value (US$ Mn), 2019 - 2032
6.5.1.7. Japan Fungal Keratitis Treatment Market by Administration, Value (US$ Mn), 2019 - 2032
6.5.1.8. Japan Fungal Keratitis Treatment Market by End User, Value (US$ Mn), 2019 - 2032
6.5.1.9. South Korea Fungal Keratitis Treatment Market by Type, Value (US$ Mn), 2019 - 2032
6.5.1.10. South Korea Fungal Keratitis Treatment Market by Drug Formulation, Value (US$ Mn), 2019 - 2032
6.5.1.11. South Korea Fungal Keratitis Treatment Market by Administration, Value (US$ Mn), 2019 - 2032
6.5.1.12. South Korea Fungal Keratitis Treatment Market by End User, Value (US$ Mn), 2019 - 2032
6.5.1.13. India Fungal Keratitis Treatment Market by Type, Value (US$ Mn), 2019 - 2032
6.5.1.14. India Fungal Keratitis Treatment Market by Drug Formulation, Value (US$ Mn), 2019 - 2032
6.5.1.15. India Fungal Keratitis Treatment Market by Administration, Value (US$ Mn), 2019 - 2032
6.5.1.16. India Fungal Keratitis Treatment Market by End User, Value (US$ Mn), 2019 - 2032
6.5.1.17. Southeast Asia Fungal Keratitis Treatment Market by Type, Value (US$ Mn), 2019 - 2032
6.5.1.18. Southeast Asia Fungal Keratitis Treatment Market by Drug Formulation, Value (US$ Mn), 2019 - 2032
6.5.1.19. Southeast Asia Fungal Keratitis Treatment Market by Administration, Value (US$ Mn), 2019 - 2032
6.5.1.20. Southeast Asia Fungal Keratitis Treatment Market by End User, Value (US$ Mn), 2019 - 2032
6.5.1.21. Rest of Asia Pacific Fungal Keratitis Treatment Market by Type, Value (US$ Mn), 2019 - 2032
6.5.1.22. Rest of Asia Pacific Fungal Keratitis Treatment Market by Drug Formulation, Value (US$ Mn), 2019 - 2032
6.5.1.23. Rest of Asia Pacific Fungal Keratitis Treatment Market by Administration, Value (US$ Mn), 2019 - 2032
6.5.1.24. Rest of Asia Pacific Fungal Keratitis Treatment Market by End User, Value (US$ Mn), 2019 - 2032
6.5.2. BPS Analysis/Market Attractiveness Analysis
7. Latin America Fungal Keratitis Treatment Market Outlook, 2019 - 2032
7.1. Latin America Fungal Keratitis Treatment Market Outlook, by Type, Value (US$ Mn), 2019 - 2032
7.1.1. Key Highlights
7.1.1.1. Aspergillus keratitis
7.1.1.2. Fusarium keratitis
7.1.1.3. Candida keratitis
7.1.1.4. Other fungal keratitis
7.2. Latin America Fungal Keratitis Treatment Market Outlook, by Drug Formulation, Value (US$ Mn), 2019 - 2032
7.2.1.1. Tablets
7.2.1.2. Eye Drops
7.2.1.3. Ophthalmic Ointments
7.2.1.4. Subconjunctival Injections
7.3. Latin America Fungal Keratitis Treatment Market Outlook, by Administration, Value (US$ Mn), 2019 - 2032
7.3.1. Key Highlights
7.3.1.1. Topical eye drops or ointments
7.3.1.2. Oral antifungal medications
7.3.1.3. Intravenous (IV) antifungal medications
7.4. Latin America Fungal Keratitis Treatment Market Outlook, by End User, Value (US$ Mn), 2019 - 2032
7.4.1. Key Highlights
7.4.1.1. Hospitals and clinics
7.4.1.2. Ophthalmic centers and eye hospitals
7.4.1.3. Ambulatory surgical centers (ASCs)
7.4.1.4. Homecare settings
7.4.2. BPS Analysis/Market Attractiveness Analysis
7.5. Latin America Fungal Keratitis Treatment Market Outlook, by Country, Value (US$ Mn), 2019 - 2032
7.5.1. Key Highlights
7.5.1.1. Brazil Fungal Keratitis Treatment Market by Type, Value (US$ Mn), 2019 - 2032
7.5.1.2. Brazil Fungal Keratitis Treatment Market by Drug Formulation, Value (US$ Mn), 2019 - 2032
7.5.1.3. Brazil Fungal Keratitis Treatment Market by Administration, Value (US$ Mn), 2019 - 2032
7.5.1.4. Brazil Fungal Keratitis Treatment Market by End User, Value (US$ Mn), 2019 - 2032
7.5.1.5. Mexico Fungal Keratitis Treatment Market by Type, Value (US$ Mn), 2019 - 2032
7.5.1.6. Mexico Fungal Keratitis Treatment Market by Drug Formulation, Value (US$ Mn), 2019 - 2032
7.5.1.7. Mexico Fungal Keratitis Treatment Market by Administration, Value (US$ Mn), 2019 - 2032
7.5.1.8. Mexico Fungal Keratitis Treatment Market by End User, Value (US$ Mn), 2019 - 2032
7.5.1.9. Argentina Fungal Keratitis Treatment Market by Type, Value (US$ Mn), 2019 - 2032
7.5.1.10. Argentina Fungal Keratitis Treatment Market by Drug Formulation, Value (US$ Mn), 2019 - 2032
7.5.1.11. Argentina Fungal Keratitis Treatment Market by Administration, Value (US$ Mn), 2019 - 2032
7.5.1.12. Argentina Fungal Keratitis Treatment Market by End User, Value (US$ Mn), 2019 - 2032
7.5.1.13. Rest of Latin America Fungal Keratitis Treatment Market by Type, Value (US$ Mn), 2019 - 2032
7.5.1.14. Rest of Latin America Fungal Keratitis Treatment Market by Drug Formulation, Value (US$ Mn), 2019 - 2032
7.5.1.15. Rest of Latin America Fungal Keratitis Treatment Market by Administration, Value (US$ Mn), 2019 - 2032
7.5.1.16. Rest of Latin America Fungal Keratitis Treatment Market by End User, Value (US$ Mn), 2019 - 2032
7.5.2. BPS Analysis/Market Attractiveness Analysis
8. Middle East & Africa Fungal Keratitis Treatment Market Outlook, 2019 - 2032
8.1. Middle East & Africa Fungal Keratitis Treatment Market Outlook, by Type, Value (US$ Mn), 2019 - 2032
8.1.1. Key Highlights
8.1.1.1. Aspergillus keratitis
8.1.1.2. Fusarium keratitis
8.1.1.3. Candida keratitis
8.1.1.4. Other fungal keratitis
8.2. Middle East & Africa Fungal Keratitis Treatment Market Outlook, by Drug Formulation, Value (US$ Mn), 2019 - 2032
8.2.1. Key Highlights
8.2.1.1. Tablets
8.2.1.2. Eye Drops
8.2.1.3. Ophthalmic Ointments
8.2.1.4. Subconjunctival Injections
8.3. Middle East & Africa Fungal Keratitis Treatment Market Outlook, by Administration, Value (US$ Mn), 2019 - 2032
8.3.1. Key Highlights
8.3.1.1. Topical eye drops or ointments
8.3.1.2. Oral antifungal medications
8.3.1.3. Intravenous (IV) antifungal medications
8.4. Middle East & Africa Fungal Keratitis Treatment Market Outlook, by End User, Value (US$ Mn), 2019 - 2032
8.4.1. Key Highlights
8.4.1.1. Hospitals and clinics
8.4.1.2. Ophthalmic centers and eye hospitals
8.4.1.3. Ambulatory surgical centers (ASCs)
8.4.1.4. Homecare settings
8.4.2. BPS Analysis/Market Attractiveness Analysis
8.5. Middle East & Africa Fungal Keratitis Treatment Market Outlook, by Country, Value (US$ Mn), 2019 - 2032
8.5.1. Key Highlights
8.5.1.1. GCC Fungal Keratitis Treatment Market by Type, Value (US$ Mn), 2019 - 2032
8.5.1.2. GCC Fungal Keratitis Treatment Market by Drug Formulation, Value (US$ Mn), 2019 - 2032
8.5.1.3. GCC Fungal Keratitis Treatment Market by Administration, Value (US$ Mn), 2019 - 2032
8.5.1.4. GCC Fungal Keratitis Treatment Market by End User, Value (US$ Mn), 2019 - 2032
8.5.1.5. South Africa Fungal Keratitis Treatment Market by Type, Value (US$ Mn), 2019 - 2032
8.5.1.6. South Africa Fungal Keratitis Treatment Market by Drug Formulation, Value (US$ Mn), 2019 - 2032
8.5.1.7. South Africa Fungal Keratitis Treatment Market by Administration, Value (US$ Mn), 2019 - 2032
8.5.1.8. South Africa Fungal Keratitis Treatment Market by End User, Value (US$ Mn), 2019 - 2032
8.5.1.9. Egypt Fungal Keratitis Treatment Market by Type, Value (US$ Mn), 2019 - 2032
8.5.1.10. Egypt Fungal Keratitis Treatment Market by Drug Formulation, Value (US$ Mn), 2019 - 2032
8.5.1.11. Egypt Fungal Keratitis Treatment Market by Administration, Value (US$ Mn), 2019 - 2032
8.5.1.12. Egypt Fungal Keratitis Treatment Market by End User, Value (US$ Mn), 2019 - 2032
8.5.1.13. Rest of Middle East & Africa Fungal Keratitis Treatment Market by Type, Value (US$ Mn), 2019 - 2032
8.5.1.14. Rest of Middle East & Africa Fungal Keratitis Treatment Market by Drug Formulation, Value (US$ Mn), 2019 - 2032
8.5.1.15. Rest of Middle East & Africa Fungal Keratitis Treatment Market by Administration, Value (US$ Mn), 2019 - 2032
8.5.1.16. Rest of Middle East & Africa Fungal Keratitis Treatment Market by End User, Value (US$ Mn), 2019 - 2032
8.5.2. BPS Analysis/Market Attractiveness Analysis
9. Competitive Landscape
9.1. By Administration vs by Drug Formulation Heat map
9.2. Manufacturer vs. Drug Formulation Heatmap
9.3. Company Market Share Analysis, 2025
9.4. Competitive Dashboard
9.5. Company Profiles
9.5.1. Novartis AG
9.5.1.1. Company Overview
9.5.1.2. Product Portfolio
9.5.1.3. Financial Overview
9.5.1.4. Business Strategies and Development
9.5.2. Eyevance Pharmaceuticals, LLC
9.5.3. AbbVie Inc.
9.5.4. Pfizer Inc.
9.5.5. Merck and Co. (Merck KGaA)
9.5.6. Bausch Health Companies Inc.
9.5.7. Cipla Inc.
9.5.8. Wellona Pharma
9.5.9. LEXICARE PHARMA PVT. LTD
9.5.10. Salvus Pharma
9.5.11. Other Players
10. Appendix
10.1. Research Methodology
10.2. Report Assumptions
10.3. Acronyms and Abbreviations

Companies Mentioned

  • Novartis AG
  • Eyevance Pharmaceuticals, LLC (Santen Holdings United States Inc.)
  • AbbVie Inc.
  • Pfizer Inc.
  • Merck and Co. (Merck KGaA)
  • Bausch Health Companies Inc.
  • Cipla Inc.
  • Wellona Pharma
  • LEXICARE PHARMA PVT. LTD
  • Salvus Pharma

Methodology

Loading
LOADING...

Related Topics

Related Reports

Fungal Keratitis Treatment Market Report: Trends, Forecast and Competitive Analysis to 2031 - Product Image

Fungal Keratitis Treatment Market Report: Trends, Forecast and Competitive Analysis to 2031

  • Report
  • 150 Pages
  • Global
From
Fungal Keratitis Treatment Market by Route of Administration, Distribution Channel - Global Forecast 2025-2030 - Product Image

Fungal Keratitis Treatment Market by Route of Administration, Distribution Channel - Global Forecast 2025-2030

  • Report
  • 184 Pages
  • Global
From
Fungal Keratitis Treatment Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2019-2029F - Product Image

Fungal Keratitis Treatment Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2019-2029F

  • Report
  • 181 Pages
  • Global
From
Fungal Keratitis Treatment Market 2024-2028 - Product Image

Fungal Keratitis Treatment Market 2024-2028

  • Report
  • 170 Pages
  • Global
From
Keratitis Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034 - Product Image

Keratitis Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

  • Report
  • 132 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.